Omkar Pharmachem Limited (BOM:532167)
28.33
+0.28 (1.00%)
At close: Oct 20, 2025
Omkar Pharmachem Revenue
Omkar Pharmachem had revenue of 1.35M INR in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 5.40M. In the fiscal year ending March 31, 2025, Omkar Pharmachem had annual revenue of 5.40M.
Revenue
5.40M
Revenue Growth
n/a
P/S Ratio
52.90
Revenue / Employee
1.35M
Employees
4
Market Cap
285.67M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.40M | - | - |
| Mar 31, 2024 | 5.40M | - | - |
| Mar 31, 2023 | 5.40M | - | - |
| Mar 31, 2022 | 5.40M | 2.70M | 100.00% |
| Mar 31, 2021 | 2.70M | 2.25M | 500.00% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.14T |
| State Bank of India | 3.57T |
| Larsen & Toubro | 2.76T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| Bharti Airtel | 1.95T |
| ICICI Bank | 1.91T |